GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.41X leverage
Performance
- Low
- ₹1,997
- High
- ₹2,079
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,074
- Previous Close₹2,080
- Volume469,242
- 50 DMA₹1,977.63
- 100 DMA₹1,936.57
- 200 DMA₹1,836.66
Investment Returns
- Over 1 Month + 2.89%
- Over 3 Month + 3.5%
- Over 6 Month + 5.42%
- Over 1 Year + 30.19%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.1
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,643
- P/B Ratio
- 5.9
- Average True Range
- 46.96
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 32.89
- RSI
- 49.94
- MFI
- 76.11
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,007.20
-72.6
(-3.49%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹2,022.43
- 50 Day
- ₹1,977.63
- 100 Day
- ₹1,936.57
- 200 Day
- ₹1,836.66
Resistance and Support
2027.73
- R3 2,140.47
- R2 2,109.73
- R1 2,058.47
- S1 1,976.47
- S2 1,945.73
- S3 1,894.47
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,007 As on 11 January, 2026 | 23:54
The Market Cap of Glenmark Pharmaceuticals is ₹56643.3 Cr As on 11 January, 2026 | 23:54
The P/E ratio of Glenmark Pharmaceuticals is 56.1 As on 11 January, 2026 | 23:54
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 11 January, 2026 | 23:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.